中芯(00981.HK)续挫16%曾低见27.5元 A股首挂飙升2.2倍曾高见95元人币
中芯国际(00981.HK)A股首挂半日收飙2.2倍,但H股继昨天续吐8%失10天线後,今早高开弹至39.9元无以为继,掉头跌破20天线(32.25元),曾急挫28%低见27.5元,现造32.15元,续挫16%,不足半日成交已进一步增至4.7亿股,为近几年罕见,涉资153.5亿元。
中芯(688981.SH)今日於沪科创板首日挂牌,股价曾飙升近2.5倍高见95元人民币,最低见80元人民币,半日收87.98元人民币,较上市价27.46元人民币,高2.2倍,半日成交达4.38亿股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.